drugset / Trial / NCT00615693

Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis

NCT00615693

Phase 2 Completed 13 enrolled Novartis
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety, tolerability, and efficacy of AEB071 as a therapy for uveitis. Vision improvement and reduction in the swelling of retina will be measured for the assessment of efficacy.

Timeline

Start
2008-07
Primary completion
2009-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject sotrastaurin Small molecule 200 mg Oral